Team:HKUST-Hong Kong

From 2011.igem.org

(Difference between revisions)
 
(31 intermediate revisions not shown)
Line 53: Line 53:
<p align=justify style="margin: 20px 20px 20px 20px">
<p align=justify style="margin: 20px 20px 20px 20px">
-
<b>Greeting from the <b>2011 HKUST iGEM Team</b>!</b><br><br>
+
<b>Greetings from the <b>2011 HKUST iGEM Team</b>!</b><br><br>
Welcome to our Wiki page!<br></p>
Welcome to our Wiki page!<br></p>
Line 60: Line 60:
<p align-justified style="margin: 20px 20px 20px 20px">
<p align-justified style="margin: 20px 20px 20px 20px">
This is the 4<sup>th</sup> time HKUST has participated in this international synthetic biology competition.<br>
This is the 4<sup>th</sup> time HKUST has participated in this international synthetic biology competition.<br>
-
Thanks to our instructors' helpful advice, considerate advisors, and great enthusiasm and effort from all member of the HKUST iGEM 2011 team, we enjoyed a fantastic summer working with something that we feel will make a difference. <br><br>
+
Thanks to our instructors' helpful advice, considerate advisors, and great enthusiasm and efforts from all members of the HKUST iGEM 2011 team, we have enjoyed a fantastic summer working with something that we believe will make a difference. <br><br>
-
You may visit our <a href=gallery.html target=_top><font color=white><u>Gallery</u></font></a> to see what we do in the lab!
+
You may visit our <a href=https://2011.igem.org/Team:HKUST-Hong_Kong/gallery.html target=_top><font color=white><u>Gallery</u></font></a> to see the snapshots of us working in the lab.
Line 86: Line 86:
<p align="left"><font size="1" face="Verdana, Arial, Helvetica, sans-serif" color="green">
<p align="left"><font size="1" face="Verdana, Arial, Helvetica, sans-serif" color="green">
-
<span style="line-height:2; font-weight:600">
+
<span style="line-height:1.8; font-weight:600">
<a href="https://2011.igem.org/Team:HKUST-Hong_Kong/overview.html" target=_top>Overview</a> |  
<a href="https://2011.igem.org/Team:HKUST-Hong_Kong/overview.html" target=_top>Overview</a> |  
<a href="https://2011.igem.org/Team:HKUST-Hong_Kong/data.html" target=_top>Data Page</a><br>
<a href="https://2011.igem.org/Team:HKUST-Hong_Kong/data.html" target=_top>Data Page</a><br>
Line 110: Line 110:
-
<div align=left height=150>
+
 
-
<img style=margin:20px src=https://static.igem.org/mediawiki/2011/d/d6/HKUST_Igem_resources.jpg width=120 height=120></div>
+
<img style=margin:20px src=https://static.igem.org/mediawiki/2011/d/d6/HKUST_Igem_resources.jpg width=120 height=120 align=left>
<p align="center" valign="baseline" ><b> <font face="Verdana, Arial, Helvetica, sans-serif" size="3" color="#D09C00">
<p align="center" valign="baseline" ><b> <font face="Verdana, Arial, Helvetica, sans-serif" size="3" color="#D09C00">
Line 122: Line 122:
<p align="left"><font size="1" face="Verdana, Arial, Helvetica, sans-serif" color="#D09C00">
<p align="left"><font size="1" face="Verdana, Arial, Helvetica, sans-serif" color="#D09C00">
-
<span style="line-height:2; font-weight:600">
+
<span style="line-height:1.3; font-weight:600">
<a href="https://2011.igem.org/Team:HKUST-Hong_Kong/acknowledgement.html" target=_top>Acknowledgements</a><br>
<a href="https://2011.igem.org/Team:HKUST-Hong_Kong/acknowledgement.html" target=_top>Acknowledgements</a><br>
The Team<br>
The Team<br>
Line 169: Line 169:
<p align="left"><font size="1" face="Verdana, Arial, Helvetica, sans-serif" color="red">
<p align="left"><font size="1" face="Verdana, Arial, Helvetica, sans-serif" color="red">
-
<span style="line-height:2; font-weight:600">
+
<span style="line-height:1.8; font-weight:600">
<a href="https://2011.igem.org/Team:HKUST-Hong_Kong/workshop.html" target=_top>Workshop</a> |
<a href="https://2011.igem.org/Team:HKUST-Hong_Kong/workshop.html" target=_top>Workshop</a> |
<a href="https://2011.igem.org/Team:HKUST-Hong_Kong/survey.html" target=_top>Survey</a>
<a href="https://2011.igem.org/Team:HKUST-Hong_Kong/survey.html" target=_top>Survey</a>
Line 198: Line 198:
<p>Our team aims to interfere with this signalling through introducing a disruptor <i>E. coli</i> into the bacterial community. This new strain will be able to degrade indole using a mutated toluene-4-monooxygenase (T4MO).  We hypothesize that LR cells in the community deprived of indole will undergo elimination at lower antibiotic concentrations. If this demonstration is successful, indole degradation might prove to be a possible strategy in boosting antibiotics effectiveness in medical practice against bacteria that rely on such signalling.</p><br>
<p>Our team aims to interfere with this signalling through introducing a disruptor <i>E. coli</i> into the bacterial community. This new strain will be able to degrade indole using a mutated toluene-4-monooxygenase (T4MO).  We hypothesize that LR cells in the community deprived of indole will undergo elimination at lower antibiotic concentrations. If this demonstration is successful, indole degradation might prove to be a possible strategy in boosting antibiotics effectiveness in medical practice against bacteria that rely on such signalling.</p><br>
-
<p>Along the way, we will also create a new strain of <i>E. coli</i> that utilizes an essential gene (<i>nadE</i>) as the selection marker for transformation, allowing antibiotics-free transformation and plasmid maintenance for regular laboratory manipulation. This new transformation method can be adopted for future iGEM teams, reducing their use of antibiotics without increasing the complexity of the transformation protocol.</p><br>
+
<p>Along the way, we will also create a new strain of <i>E. coli</i> that utilizes an essential gene (<i>nadE</i>) as the selection marker for transformation, allowing antibiotics-free transformation and plasmid maintenance for regular laboratory manipulation. This new transformation method can be adopted for future iGEM teams, reducing their use of antibiotics without increasing the complexity of the transformation protocol.</p><br><br><br>
</font>
</font>
</font>
</font>
Line 268: Line 268:
<p align="center" valign="baseline">
<p align="center" valign="baseline">
-
<a href="https://2011.igem.org/Team:HKUST-Hong_Kong/medal.html" target=_top>Medal Requirements<font color="#FFF4D0"> | </font>
+
<a href="https://2011.igem.org/Team:HKUST-Hong_Kong/medal.html" target=_top>Medal Requirements</a><font color="#FFF4D0"> | </font>
<a href="https://2011.igem.org/Team:HKUST-Hong_Kong/biosafety.html" target=_top>BioSafety</a><br></p>
<a href="https://2011.igem.org/Team:HKUST-Hong_Kong/biosafety.html" target=_top>BioSafety</a><br></p>
Line 288: Line 288:
<p align="center" valign="baseline">
<p align="center" valign="baseline">
-
<a href="https://2011.igem.org/Team:HKUST-Hong_Kong/workshop.html" target=_top>Workshop<font color="white"> | </font>
+
<a href="https://2011.igem.org/Team:HKUST-Hong_Kong/workshop.html" target=_top>Workshop</a><font color="white"> | </font>
<a href="https://2011.igem.org/Team:HKUST-Hong_Kong/survey.html" target=_top>Survey</a><br></p>
<a href="https://2011.igem.org/Team:HKUST-Hong_Kong/survey.html" target=_top>Survey</a><br></p>

Latest revision as of 16:49, 27 October 2011


Greetings from the 2011 HKUST iGEM Team!

Welcome to our Wiki page!

This is the 4th time HKUST has participated in this international synthetic biology competition.
Thanks to our instructors' helpful advice, considerate advisors, and great enthusiasm and efforts from all members of the HKUST iGEM 2011 team, we have enjoyed a fantastic summer working with something that we believe will make a difference.

You may visit our Gallery to see the snapshots of us working in the lab.


Our Project

Overview | Data Page
Experiments and Results
Strain Construction | Culture Tests | Modeling
Miscellaneous
Notebook


iGEM Resources

Acknowledgements
The Team
iGem Member List | Contributions
Achievements
Medal Requirements | BioSafety
BioBricks
Master List & Characterization Data


Human Practice

Workshop | Survey

Project Abstract


It has often been assumed that when an antibiotic is introduced to a bacterial community, only cells that carry resistance genes will survive and proliferate. However, recent findings suggest that communities with a mixture of highly resistant (HR) and less resistant (LR) individuals are able to survive through ‘charity’ by HR individuals, which support LR individuals through indole signalling.


Our team aims to interfere with this signalling through introducing a disruptor E. coli into the bacterial community. This new strain will be able to degrade indole using a mutated toluene-4-monooxygenase (T4MO). We hypothesize that LR cells in the community deprived of indole will undergo elimination at lower antibiotic concentrations. If this demonstration is successful, indole degradation might prove to be a possible strategy in boosting antibiotics effectiveness in medical practice against bacteria that rely on such signalling.


Along the way, we will also create a new strain of E. coli that utilizes an essential gene (nadE) as the selection marker for transformation, allowing antibiotics-free transformation and plasmid maintenance for regular laboratory manipulation. This new transformation method can be adopted for future iGEM teams, reducing their use of antibiotics without increasing the complexity of the transformation protocol.




Home

Our Project

Overview | Data Page

Experiments and Results

Strain Construction | Culture Tests | Modeling

Miscellaneous

Notebook

iGEM Resources

Acknowledgements

The Team

iGEM Member List | Contributions

Achievements

Medal Requirements | BioSafety

BioBricks

Master List & Characterization Data

Human Practice

Workshop | Survey